Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,220 | 20,761 | 7,165 | 5,934 | 5,373 |
| Depreciation Amortization | 809 | 984 | 1,172 | 1,933 | 2,191 |
| Income taxes - deferred | 75 | -47 | 108 | -26 | -13 |
| Accounts receivable | -226 | 36 | 577 | 164 | 57 |
| Accounts payable and accrued liabilities | 312 | -291 | 154 | -208 | 149 |
| Other Working Capital | 15,953 | -14,371 | -161 | -117 | 239 |
| Other Operating Activity | 316 | 1,263 | -359 | 180 | -171 |
| Operating Cash Flow | $27,459 | $8,335 | $8,656 | $7,860 | $7,825 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -411 | -272 | -517 | -524 | -350 |
| Net Acquisitions | -1,012 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -22,103 | -737 | N/A | N/A | N/A |
| Sale Of Investment | 8,202 | 98 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -10 | -122 | N/A | N/A | -250 |
| Other Investing Activity | -10 | -122 | 0 | 0 | -250 |
| Investing Cash Flow | $-15,334 | $-1,033 | $-517 | $-524 | $-600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,956 | N/A | 8,950 |
| Debt Repayment | N/A | -4,956 | -2,501 | -7,499 | -4,884 |
| Common Stock Issued | 1,111 | 882 | 1,113 | 316 | 85 |
| Common Stock Repurchased | -10,698 | -2,795 | -11,818 | -193 | -11,598 |
| Dividend Paid | -1,331 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-10,918 | $-6,869 | $-8,250 | $-7,376 | $-7,447 |
| Exchange Rate Effect | -151 | 44 | 26 | -4 | -11 |
| Beginning Cash Position | 762 | 285 | 370 | 414 | 647 |
| End Cash Position | 1,818 | 762 | 285 | 370 | 414 |
| Net Cash Flow | $1,056 | $477 | $-85 | $-44 | $-233 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,459 | 8,335 | 8,656 | 7,860 | 7,825 |
| Capital Expenditure | -411 | -272 | -517 | -524 | -361 |
| Free Cash Flow | 27,048 | 8,063 | 8,139 | 7,336 | 7,464 |